Gary W Pace - Net Worth and Insider Trading
Gary W Pace Net Worth
The estimated net worth of Gary W Pace is at least $25 Million dollars as of 2024-05-08. Gary W Pace is the Director of ResMed Inc and owns about 100,578 shares of ResMed Inc (RMD) stock worth over $22 Million. Gary W Pace is the Director of Cardiff Oncology Inc and owns about 697,761 shares of Cardiff Oncology Inc (CRDF) stock worth over $2 Million. Gary W Pace is also the Director of Pacira BioSciences Inc and owns about 22,127 shares of Pacira BioSciences Inc (PCRX) stock worth over $586,587. Details can be seen in Gary W Pace's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gary W Pace has not made any transactions after 2024-03-08 and currently still holds the listed stock(s).
Transaction Summary of Gary W Pace
Gary W Pace Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary W Pace owns 4 companies in total, including Pacira BioSciences Inc (PCRX) , Cardiff Oncology Inc (CRDF) , and ResMed Inc (RMD) among others .
Click here to see the complete history of Gary W Pace’s form 4 insider trades.
Insider Ownership Summary of Gary W Pace
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2024-03-08 | director |
| CRDF | Cardiff Oncology Inc | 2023-12-19 | director |
| RMD | ResMed Inc | 2018-05-08 | director |
 | | 2006-03-15 | director |
Gary W Pace Latest Holdings Summary
Gary W Pace currently owns a total of 3 stocks. Among these stocks, Gary W Pace owns 100,578 shares of ResMed Inc (RMD) as of May 8, 2018, with a value of $22 Million and a weighting of 88.22%. Gary W Pace owns 697,761 shares of Cardiff Oncology Inc (CRDF) as of December 19, 2023, with a value of $2 Million and a weighting of 9.4%. Gary W Pace also owns 22,127 shares of Pacira BioSciences Inc (PCRX) as of March 8, 2024, with a value of $586,587 and a weighting of 2.38%.
Latest Holdings of Gary W Pace
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RMD | ResMed Inc | 2018-05-08 | 100,578 | 216.16 | 21,740,940 |
| CRDF | Cardiff Oncology Inc | 2023-12-19 | 697,761 | 3.32 | 2,316,567 |
| PCRX | Pacira BioSciences Inc | 2024-03-08 | 22,127 | 26.51 | 586,587 |
Holding Weightings of Gary W Pace
Gary W Pace Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary W Pace has made a total of 0 transactions in ResMed Inc (RMD) over the past 5 years. The most-recent trade in ResMed Inc is the sale of 28,403 shares on May 8, 2018, which brought Gary W Pace around $3 Million.
According to the SEC Form 4 filings, Gary W Pace has made a total of 9 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 30,000 shares on December 19, 2023, which cost Gary W Pace around $41,100.
According to the SEC Form 4 filings, Gary W Pace has made a total of 3 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 119,323 shares on March 8, 2024, which brought Gary W Pace around $4 Million.
Insider Trading History of Gary W Pace
- 1
Gary W Pace Trading Performance
GuruFocus tracks the stock performance after each of Gary W Pace's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary W Pace is 62.71%. GuruFocus also compares Gary W Pace's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary W Pace within 3 months outperforms 6 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gary W Pace's insider trading performs compared to the benchmark.
Performance of Gary W Pace
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.12 | | | | | |
| Relative Return to S&P 500(%) | 16.07 | | | | | |
Gary W Pace Ownership Network
Gary W Pace Owned Company Details
What does Pacira BioSciences Inc do?
Who are the key executives at Pacira BioSciences Inc?
Gary W Pace is the director of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Clinical Officer Roy Winston , Executive Director & Accounting Lauren Bullaro Riker , and CAO and General Counsel Kristen Marie Williams .
Pacira BioSciences Inc (PCRX) Insider Trades Summary
Over the past 18 months, Gary W Pace made 2 insider transaction in Pacira BioSciences Inc (PCRX) with a net sale of 124,338. Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 8,216 shares made by Lauren Bullaro Riker , a net sale of 9,125 shares made by Kristen Marie Williams , and a net sale of 7,600 shares made by Laura Brege .
In summary, during the past 3 months, insiders sold 119,323 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 119,323 shares. During the past 18 months, 209,500 shares of Pacira BioSciences Inc (PCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209,500 shares.
Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pacira BioSciences Inc Insider Transactions
Gary W Pace Mailing Address
Above is the net worth, insider trading, and ownership report for Gary W Pace. You might contact Gary W Pace via mailing address: C/o Resmed Inc, 14040 Danielson Street, Poway Ca 92064-6857.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
